Wedbush Securities Inc Ardelyx, Inc. Transaction History

Wedbush Securities Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 16, 2020	SELL	$4.23 - $8.29 $126,223 - $247,373	-29,840 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$2.15 - $6.28 $323,996 - $946,370	-150,696 Reduced 83.47%	29,840 $140,000
Q2 2019 Aug 01, 2019	SELL	$2.49 - $3.73 $30,427 - $45,580	-12,220 Reduced 6.34%	180,536 $486,000
Q1 2019 Apr 17, 2019	BUY	$1.88 - $3.35 $93,240 - $166,146	49,596 Added 34.64%	192,756 $540,000
Q4 2018 Jan 31, 2019	BUY	$1.66 - $4.16 $177,371 - $444,496	106,850 Added 294.27%	143,160 $256,000
Q3 2018 Nov 13, 2018	BUY	$3.75 - $4.65 $136,162 - $168,841	36,310 New	36,310 $158,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.